Seaport Therapeutics, Inc. Common Stock

NASDAQ:SPTX

Biotechnology

Healthcare
$18.31 +0.58%

+$0.10 today

Market cap
$980.14M
Beta
0.00
52W Low $14.85High $23.00

Volume 0.68M

Average 0.41M

SPTX Other Current Liabilities

Short-term obligations not reported separately, such as accrued expenses.

No reported Other Current Liabilities figures are available to summarize.

Other Current Liabilities history

Currency unavailable · from the balance sheet

No Other Current Liabilities data reported for this period type.

Other Current Liabilities vs competitors

How SPTX compares with its peers on the latest reported figures

SPTX Competitors
Other Current Liabilities for SPTX and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
VNDAVanda Pharmaceuticals Inc.Mar 2026$81.65M USD+30.8%+36.9%18.8%
NMRANeumora Therapeutics, Inc. Common StockMar 2026$24.77M USD+294.3%+42.0%16.1%
MPLTMapLight Therapeutics, Inc.Mar 2026$11.15M USD+65.0%+89.8%2.7%
GHRSGH Research PLCMar 2026$6.25M USD+29.9%+9.3%2.3%
RAPPRapport Therapeutics, Inc. Common StockMar 2026$3.08M USD+46.6%—0.6%
LBRXLB Pharmaceuticals Inc Common StockMar 2026$1.97M USD—+136.0%0.5%
CTNMContineum Therapeutics, Inc. Class A Common StockMar 2026$1.29M USD+8.3%+6.7%0.5%
SPTXSeaport Therapeutics, Inc. Common Stock—— ———
Peer median (excluding SPTX) —+38.7%+39.5%2.3%

Competitors are the stored peer set for SPTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Seaport Therapeutics, Inc. Common Stock

NASDAQ:SPTX

Intrinsic Alpha fair value

Locked

Current Price

$18.31

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.